search
Back to results

Comparison of the Efficacy of Double Monopolar Versus Interleaving Stimulation Modes for Pallidal Deep Brain Stimulation

Primary Purpose

Primary Dystonia

Status
Completed
Phase
Not Applicable
Locations
Hungary
Study Type
Interventional
Intervention
Interleaving stimulation mode (Medtronic)
Double monopolar stimulation mode (Medtronic)
Sponsored by
University of Pecs
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Primary Dystonia focused on measuring dystonia, pallidal stimulation, deep brain stimulation, deep brain stimulation of GPi, GPi, interleaving stimulation

Eligibility Criteria

7 Years - 75 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ages of 7 and 75 years
  • marked disability owing to primary generalized or segmental dystonia, despite optimal pharmacologic treatment
  • disease duration of at least 5 years.

Exclusion Criteria:

  • previous brain surgery;
  • cognitive impairment (< 120 points on the Mattis Dementia Rating Scale)
  • moderate-to-severe depression (> 25 points on the Beck Depression Inventory)
  • marked brain atrophy as detected by magnetic resonance imaging
  • other medical or psychiatric coexisting disorders that could increase the surgical risk or interfere with completion of the trial

Sites / Locations

  • Department of Neurology, University of Pécs

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Process 1

Process 2

Arm Description

Visit 1: Baseline evaluation (maximum 1 week before operation) Visit 2: Testing of electrodes and subsequent initiation of interleaving stimulation mode (4th postoperative week). Visit 3 Evaluation and cross-over to double-monopolar stimulation mode (16th postoperative week). Visit 4 Final evaluation. (28th postoperative week).

Visit 1: Baseline evaluation (maximum 1 week before operation) Visit 2: Testing of electrodes and subsequent initiation of double-monopolar stimulation mode (4th postoperative week). Visit 3 Evaluation and cross-over to interleaving stimulation mode (16th postoperative week). Visit 4 Final evaluation. (28th postoperative week).

Outcomes

Primary Outcome Measures

Differences in severity of dystonia
Differences in severity of dystonia measured by Burke-Fahn-Marsden Dystonia Rating Scale

Secondary Outcome Measures

Number of treatment responders after three months deep brain stimulation
Differences in number of treatment responders (at least 25% improvement on Burke-Fahn-Marsden Dystonia Rating Scale compared to baseline)
Health-related quality of life after three months deep brain stimulation
Differences in health-related quality of life measured by EQ-5D and SF-36 scales
Side-effect profile after three months deep brain stimulation
Differences in side-effect profile measured by stuctured deep brain stimulation-related side-effect questionnaire

Full Information

First Posted
December 14, 2011
Last Updated
November 22, 2018
Sponsor
University of Pecs
search

1. Study Identification

Unique Protocol Identification Number
NCT01497639
Brief Title
Comparison of the Efficacy of Double Monopolar Versus Interleaving Stimulation Modes for Pallidal Deep Brain Stimulation
Official Title
Comparison of the Efficacy of Double Monopolar Versus Interleaving Stimulation Modes for the Deep Brain Stimulation Treatment of Primary Generalized or Segmental Dystonia
Study Type
Interventional

2. Study Status

Record Verification Date
November 2018
Overall Recruitment Status
Completed
Study Start Date
March 2012 (Actual)
Primary Completion Date
June 7, 2018 (Actual)
Study Completion Date
June 7, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pecs

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of the study is to compare the efficacy and the safety profile of the newly introduced interleaving stimulation mode to those of the standard double monopolar stimulation mode during pallidal deep brain stimulation of primary generalized or segmental dystonia.
Detailed Description
Background: For the treatment of drug-refractory dystonia, bilateral pallidal deep brain stimulation (GPi-DBS) is proven to be an efficient option. On average, 40-55% improvement on dystonia rating scales (DRS) could be achieved according to the results of multicenter trials lasting for years. However, a considerable portion (10-25%) of the patients experience minimal alleviation despite of good electrode placement. These patients can be regarded as non-responders to GPi-DBS defined as having either limited improvement (< 25% on DRS) or worsening. Besides adjusting the amplitude, frequency or pulse-width of stimulation, one can change the electrode configuration from the commonly applied single monopolar stimulation mode (one contact on the electrode is negative) to either double monopolar stimulation (two -usually adjacent- negative contacts on the electrode are stimulated with same amplitude and pulse-width values) or bipolar stimulation mode (one contact on the electrode is positive) in case of unsatisfactory outcomes. Although these techniques had been utilized in multicenter trials, non-responsiveness to GPi-DBS did occur. Recently the investigators have reported in the Movement Disorders that the newly introduced interleaving stimulation mode was superior to single or double monopolar stimulation in four patients who had initially (6-12 months after implantation) limited response to GPi DBS. Aims of the study: To systematically compare the efficacy and the side-effect profile of double monopolar stimulation mode to those of interleaving stimulation mode in a prospective, randomized, double-blind, and cross-over study. Methods: The investigators would enroll 20-25 patients with drug refractory segmental or generalized primary dystonia undergoing bilateral GPi-DBS implantation within a 2-3 year time frame. The inclusion and exclusion criteria would follow those of the study of Kupsch et al.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Primary Dystonia
Keywords
dystonia, pallidal stimulation, deep brain stimulation, deep brain stimulation of GPi, GPi, interleaving stimulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
34 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Process 1
Arm Type
Active Comparator
Arm Description
Visit 1: Baseline evaluation (maximum 1 week before operation) Visit 2: Testing of electrodes and subsequent initiation of interleaving stimulation mode (4th postoperative week). Visit 3 Evaluation and cross-over to double-monopolar stimulation mode (16th postoperative week). Visit 4 Final evaluation. (28th postoperative week).
Arm Title
Process 2
Arm Type
Active Comparator
Arm Description
Visit 1: Baseline evaluation (maximum 1 week before operation) Visit 2: Testing of electrodes and subsequent initiation of double-monopolar stimulation mode (4th postoperative week). Visit 3 Evaluation and cross-over to interleaving stimulation mode (16th postoperative week). Visit 4 Final evaluation. (28th postoperative week).
Intervention Type
Device
Intervention Name(s)
Interleaving stimulation mode (Medtronic)
Other Intervention Name(s)
Medtronic Activa RC Interleaving Stimulation Mode
Intervention Description
Interleaving stimulation mode with constant frequency (125 Hz) and pulse-width (120us)parameters 'Interleavingr stimulation mode (Medtronic)'
Intervention Type
Device
Intervention Name(s)
Double monopolar stimulation mode (Medtronic)
Other Intervention Name(s)
Medtronic Activa RC Double Monopolar Stimulation Mode
Intervention Description
Double monopolar stimulation mode with constant frequency (125 Hz) and pulse-width (120us)parameters 'Double monopolar stimulation mode (Medtronic)'
Primary Outcome Measure Information:
Title
Differences in severity of dystonia
Description
Differences in severity of dystonia measured by Burke-Fahn-Marsden Dystonia Rating Scale
Time Frame
7 months
Secondary Outcome Measure Information:
Title
Number of treatment responders after three months deep brain stimulation
Description
Differences in number of treatment responders (at least 25% improvement on Burke-Fahn-Marsden Dystonia Rating Scale compared to baseline)
Time Frame
7 months
Title
Health-related quality of life after three months deep brain stimulation
Description
Differences in health-related quality of life measured by EQ-5D and SF-36 scales
Time Frame
7 months
Title
Side-effect profile after three months deep brain stimulation
Description
Differences in side-effect profile measured by stuctured deep brain stimulation-related side-effect questionnaire
Time Frame
7 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ages of 7 and 75 years marked disability owing to primary generalized or segmental dystonia, despite optimal pharmacologic treatment disease duration of at least 5 years. Exclusion Criteria: previous brain surgery; cognitive impairment (< 120 points on the Mattis Dementia Rating Scale) moderate-to-severe depression (> 25 points on the Beck Depression Inventory) marked brain atrophy as detected by magnetic resonance imaging other medical or psychiatric coexisting disorders that could increase the surgical risk or interfere with completion of the trial
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Norbert Kovacs, MD, PhD
Organizational Affiliation
Associate professor, Department of Neurology, University of Pecs
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Neurology, University of Pécs
City
Pécs
State/Province
Baranya Megye
ZIP/Postal Code
H-7623
Country
Hungary

12. IPD Sharing Statement

Citations:
PubMed Identifier
17093249
Citation
Kupsch A, Benecke R, Muller J, Trottenberg T, Schneider GH, Poewe W, Eisner W, Wolters A, Muller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Vollmer-Haase J, Brentrup A, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Naumann M, Volkmann J; Deep-Brain Stimulation for Dystonia Study Group. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med. 2006 Nov 9;355(19):1978-90. doi: 10.1056/NEJMoa063618.
Results Reference
background
PubMed Identifier
15689584
Citation
Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, Lagrange C, Tezenas du Montcel S, Dormont D, Grand S, Blond S, Detante O, Pillon B, Ardouin C, Agid Y, Destee A, Pollak P; French Stimulation du Pallidum Interne dans la Dystonie (SPIDY) Study Group. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med. 2005 Feb 3;352(5):459-67. doi: 10.1056/NEJMoa042187.
Results Reference
background
PubMed Identifier
19744963
Citation
Valldeoriola F, Regidor I, Minguez-Castellanos A, Lezcano E, Garcia-Ruiz P, Rojo A, Salvador A, Castro A, Grandas F, Kulisevsky J, Marti MJ, Martinez-Martin P, Relova L, Rumia J, Camara A, Burguera JA, Linazasoro G, de Val JL, Obeso J, Rodriguez-Oroz MC, Tolosa E; Grupo ESpanol para el EStudio de la EStimulacion PALidal en la DIStonia. Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study. J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):65-9. doi: 10.1136/jnnp.2009.174342. Epub 2009 Sep 10.
Results Reference
background
PubMed Identifier
17303528
Citation
Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Lagrange C, Yelnik J, Bardinet E, Benabid AL, Navarro S, Dormont D, Grand S, Blond S, Ardouin C, Pillon B, Dujardin K, Hahn-Barma V, Agid Y, Destee A, Pollak P; French SPIDY Study Group. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol. 2007 Mar;6(3):223-9. doi: 10.1016/S1474-4422(07)70035-2.
Results Reference
background
PubMed Identifier
21692111
Citation
Kupsch A, Tagliati M, Vidailhet M, Aziz T, Krack P, Moro E, Krauss JK. Early postoperative management of DBS in dystonia: programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting. Mov Disord. 2011 Jun;26 Suppl 1:S37-53. doi: 10.1002/mds.23624.
Results Reference
background
PubMed Identifier
21956680
Citation
Kovacs N, Janszky J, Nagy F, Balas I. Changing to interleaving stimulation might improve dystonia in cases not responding to pallidal stimulation. Mov Disord. 2012 Jan;27(1):163-5. doi: 10.1002/mds.23962. Epub 2011 Sep 28. No abstract available.
Results Reference
background
PubMed Identifier
21692113
Citation
Tagliati M, Krack P, Volkmann J, Aziz T, Krauss JK, Kupsch A, Vidailhet AM. Long-Term management of DBS in dystonia: response to stimulation, adverse events, battery changes, and special considerations. Mov Disord. 2011 Jun;26 Suppl 1:S54-62. doi: 10.1002/mds.23535.
Results Reference
background

Learn more about this trial

Comparison of the Efficacy of Double Monopolar Versus Interleaving Stimulation Modes for Pallidal Deep Brain Stimulation

We'll reach out to this number within 24 hrs